In a major expansion of its neurosurgery program, NewYork-Presbyterian Hospital Weill Cornell Medical Center has named Dr. Susan Pannullo as its first Director of Neuro-Oncology in the Department of Neurological Surgery.

Disproving a widely held belief and a common urban myth, a new NewYork Weill Cornell Medical Center study shows that New York City police officers are less likely to commit suicide than the average New York City citizen.

Gleevec, the new anti-leukemia drug from Novartis Pharmaceuticals, achieves a marked improvement in survival even for patients in the accelerated phase of chronic myeloid leukemia (CML), according to a study to be presented on Monday afternoon, Dec. 9, at the meeting of the American Society of Hematology (ASH) in Philadelphia.

This intensive, hands-on field and laboratory course provided a unique and interdisciplinary curriculum that included aspects of field botany, evaluations of phytochemical diversity, and basic chemical-ecological assessments of biological activity.

Scientists at Weill Cornell Medical College, led by Dr. Carl Nathan, have now found that Mtb defends itself against oxidative stress by using a "bucket brigade" of proteins --­ including two proteins that have been widely known as being involved in essential metabolism.

Researchers at NewYork-Presbyterian Hospital's Weill Cornell Medical Center today announced initial phase II study results that suggest the addition of celecoxib (CELEBREX®) to paclitaxel/carboplatin, a common chemotherapy regimen, contributed to a clinical response in non-small cell lung cancer patients prior to surgery.

Gerald M. Loughlin, M.D., has been appointed Chairman of Pediatrics at NewYork Weill Cornell Children's Hospital of NewYork-Presbyterian.

A large, randomized study of more than 3,000 New York City schoolchildren (mostly African-American and Hispanic) has shown for the first time that a school-based prevention program that teaches early adolescents drug refusal skills and other essential behaviors can significantly decrease binge drinking for as long as two years after the initial intervention.